
Odiwac S 500mg/250mg Injection
Marketer
Oddiant Formulations
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Odiwac S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic, indicated for treating diverse bacterial infections. It combats microorganisms, inhibiting their proliferation and infection spread. Administration of Combiflox 500mg/250mg Injection must be under a doctor's direct supervision. Adhere strictly to the prescribed dosage schedule; complete the full course even with symptom improvement. Premature cessation may compromise treatment efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea, etc.). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it usually doesn't impair driving, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and ample hydration are crucial for optimal recovery. Your doctor may order blood tests and other assessments to monitor the medication's effects.
Primary Ingredients of Odiwac S 500mg/250mg Injection
There is no text provided to rephrase.
Uses of Odiwac S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Odiwac S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Odiwac S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Odiwac S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Odiwac S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Odiwac S 500mg/250mg Injection, offer a dual antibiotic approach. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Odiwac S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Odiwac S (500mg/250mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Odiwac S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Odiwac S 500mg/250mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Odiwac S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The 500mg/250mg Odiwac S Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dosage of the 500mg/250mg Odiwac S Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Odiwac S 500mg/250mg Injection :
Should you forget to take a dose of Odiwac S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Odiwac S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
